Loading...

Marc Levin, MD, PhD

TitleAssistant Clinical Professor
SchoolUCSF School of Medicine
DepartmentOphthalmology
Address10 Koret Way
San Francisco CA 94117
Phone415-353-2802
EmailMarc.Levin@ucsf.edu
vCardDownload vCard

    Collapse Biography 
    Collapse Education and Training
    University of California, San FranciscoM.D.2008 Medicine
    University of California, San FranciscoPh.D.2006 Graduate Division

    Collapse Overview 

    Collapse Research 
    Collapse Research Activities and Funding
    Optic neuritis in aquaporin-4-IgG seropositive neuromyelitis optica
    NIH K08EY023981Sep 30, 2014 - Sep 29, 2019
    Role: Principal Investigator

    Collapse ORNG Applications 
    Collapse Clinical Trials

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
    List All   |   Timeline
    1. Felix CM, Lee S, Levin M, Verkman AS. Pro-Secretory Activity and Pharmacology in Rabbits of an Aminophenyl-1,3,5-Triazine CFTR Activator for Dry Eye Disorders. Invest Ophthalmol Vis Sci. 2017 Sep 01; 58(11):4506-4513. PMID: 28873176.
      View in: PubMed
    2. Levin M. Advances in Neuromyelitis Optica: Take Them to the Clinic. J Neuroophthalmol. 2017 Sep; 37(3):300-302. PMID: 28376022.
      View in: PubMed
    3. Hsia YC, Chin-Hong PV, Levin M. Epstein-Barr Virus Neuroretinitis in a Lung Transplant Patient. J Neuroophthalmol. 2017 Mar; 37(1):43-47. PMID: 27525478.
      View in: PubMed
    4. Kalin-Hajdu E, Vagefi MR, Levin M. Recalcitrant Orbital Pain in a 50-Year-Old Woman. JAMA Ophthalmol. 2017 Mar 01; 135(3):275-276. PMID: 28006057.
      View in: PubMed
    5. Lee S, Phuan PW, Felix CM, Tan JA, Levin M, Verkman AS. Nanomolar-Potency Aminophenyl-1,3,5-triazine Activators of the Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Chloride Channel for Prosecretory Therapy of Dry Eye Diseases. J Med Chem. 2017 Feb 09; 60(3):1210-1218. PMID: 28099811.
      View in: PubMed
    6. Sagan SA, Winger RC, Cruz-Herranz A, Nelson PA, Hagberg S, Miller CN, Spencer CM, Ho PP, Bennett JL, Levy M, Levin M, Verkman AS, Steinman L, Green AJ, Anderson MS, Sobel RA, Zamvil SS. Tolerance checkpoint bypass permits emergence of pathogenic T cells to neuromyelitis optica autoantigen aquaporin-4. Proc Natl Acad Sci U S A. 2016 Dec 20; 113(51):14781-14786. PMID: 27940915.
      View in: PubMed
    7. Felix CM, Levin M, Verkman AS. Complement-independent retinal pathology produced by intravitreal injection of neuromyelitis optica immunoglobulin G. J Neuroinflammation. 2016 Oct 20; 13(1):275. PMID: 27765056.
      View in: PubMed
    8. Flores AM, Casey SD, Felix CM, Phuan PW, Verkman AS, Levin M. Small-molecule CFTR activators increase tear secretion and prevent experimental dry eye disease. FASEB J. 2016 May; 30(5):1789-97. PMID: 26842854; PMCID: PMC4836376 [Available on 05/01/17].
    9. Cil O, Phuan PW, Lee S, Tan J, Haggie PM, Levin M, Sun L, Thiagarajah JR, Ma T, Verkman AS, et al. CFTR activator increases intestinal fluid secretion and normalizes stool output in a mouse model of constipation. Cell Mol Gastroenterol Hepatol. 2016 May; 2(3):317-327. PMID: 27127798.
      View in: PubMed
    10. Schubert RD, Wood M, Levin M, Perry A, Gelfand JM. The severe side of the IgG4-related hypertrophic pachymeningitis disease spectrum. Neurol Neuroimmunol Neuroinflamm. 2016 Feb; 3(1):e197. PMID: 26770998; PMCID: PMC4708924.
    11. Levin M, Armstrong GT, Broad JH, Zimmerman R, Bilaniuk LT, Feygin T, Li Y, Liu GT, Fisher MJ. Risk of optic pathway glioma in children with neurofibromatosis type 1 and optic nerve tortuosity or nerve sheath thickening. Br J Ophthalmol. 2016 Apr; 100(4):510-4. PMID: 26294105.
      View in: PubMed
    12. Nagia L, Doyle JI, Hackney JR, Vaphiades MS, Kline LB, Levin M. Second chances. Surv Ophthalmol. 2015 Nov-Dec; 60(6):596-9. PMID: 26079932.
      View in: PubMed
    13. Indaram M, Ali FS, Levin M. In search of a treatment for radiation-induced optic neuropathy. Curr Treat Options Neurol. 2015 Jan; 17(1):325. PMID: 25398466.
      View in: PubMed
    14. Levin M, Gopal PP, Galetta SL. Systemic inflammatory pseudotumor and myasthenia gravis. JAMA Ophthalmol. 2014 Mar; 132(3):359-61. PMID: 24626829.
      View in: PubMed
    15. Asavapanumas N, Ratelade J, Papadopoulos MC, Bennett JL, Levin M, Verkman AS. Experimental mouse model of optic neuritis with inflammatory demyelination produced by passive transfer of neuromyelitis optica-immunoglobulin G. J Neuroinflammation. 2014 Jan 27; 11:16. PMID: 24468108; PMCID: PMC3909205.
    16. Levin M, Pistilli M, Daniel E, Gangaputra SS, Nussenblatt RB, Rosenbaum JT, Suhler EB, Thorne JE, Foster CS, Jabs DA, Levy-Clarke GA, Kempen JH. Incidence of visual improvement in uveitis cases with visual impairment caused by macular edema. Ophthalmology. 2014 Feb; 121(2):588-95.e1. PMID: 24332536; PMCID: PMC3946576.
    17. Levin M, Bennett JL, Verkman AS. Optic neuritis in neuromyelitis optica. Prog Retin Eye Res. 2013 Sep; 36:159-71. PMID: 23545439; PMCID: PMC3770284.
    18. Levin M, Moss HE, Pineles SL, Bagley LJ, Heuer GG, Zager EL, Balcer LJ, Galetta SL, Vagefi MR. Orbital congestion complicating treatment of cerebral vascular anomalies. World Neurosurg. 2014 Jul-Aug; 82(1-2):239.e13-7. PMID: 23369940; PMCID: PMC3766429.
    19. Levin M, Ney JJ, Venneti S, Moster ML, Balcer LJ, Volpe NJ, Gausas RE, Liu GT, Vagefi MR, Galetta SL. Optic nerve biopsy in the management of progressive optic neuropathy. J Neuroophthalmol. 2012 Dec; 32(4):313-20. PMID: 22684127.
      View in: PubMed
    20. Wehrli SJ, Tawse K, Levin M, Zaidi A, Pistilli M, Brucker AJ. A lack of delayed intraocular pressure elevation in patients treated with intravitreal injection of bevacizumab and ranibizumab. Retina. 2012 Jul; 32(7):1295-301. PMID: 22466465.
      View in: PubMed
    21. Levin M, Gombos DS, O'Brien JM. Intra-arterial chemotherapy for advanced retinoblastoma: is the time right for a prospective clinical trial? Arch Ophthalmol. 2011 Nov; 129(11):1487-9. PMID: 22084219.
      View in: PubMed
    22. Levin M, O'Brien JM. Adult ovarian retinoblastoma genomic profile. JAMA. 2011 Aug 10; 306(6):646-7. PMID: 21834141.
      View in: PubMed
    23. Venneti S, Moss HE, Levin M, Vagefi MR, Brozena SC, Pruitt AA, Mourelatos Z, Trojanowski JQ, Galetta SL, Balcer LJ. Asymmetric bilateral demyelinating optic neuropathy from tacrolimus toxicity. J Neurol Sci. 2011 Feb 15; 301(1-2):112-5. PMID: 21112060.
      View in: PubMed
    24. Levin M, Naseri A, Stewart JM. Resident-performed prophylactic retinopexy and the risk of retinal detachment. Ophthalmic Surg Lasers Imaging. 2009 Mar-Apr; 40(2):120-6. PMID: 19320300.
      View in: PubMed
    25. Ruiz-Ederra J, Levin M, Verkman AS. In situ fluorescence measurement of tear film [Na+], [K+], [Cl-], and pH in mice shows marked hypertonicity in aquaporin-5 deficiency. Invest Ophthalmol Vis Sci. 2009 May; 50(5):2132-8. PMID: 19136711; PMCID: PMC2904304.
    26. Verkman AS, Ruiz-Ederra J, Levin M. Functions of aquaporins in the eye. Prog Retin Eye Res. 2008 Jul; 27(4):420-33. PMID: 18501660; PMCID: PMC3319433.
    27. Zhao D, Sonawane ND, Levin M, Yang B. Comparative transport efficiencies of urea analogues through urea transporter UT-B. Biochim Biophys Acta. 2007 Jul; 1768(7):1815-21. PMID: 17506977.
      View in: PubMed
    28. Levin M, de la Fuente R, Verkman AS. Urearetics: a small molecule screen yields nanomolar potency inhibitors of urea transporter UT-B. FASEB J. 2007 Feb; 21(2):551-63. PMID: 17202246.
      View in: PubMed
    29. Levin M, Verkman AS. Aquaporin-3-dependent cell migration and proliferation during corneal re-epithelialization. Invest Ophthalmol Vis Sci. 2006 Oct; 47(10):4365-72. PMID: 17003427.
      View in: PubMed
    30. Levin M, Verkman AS. Aquaporins and CFTR in ocular epithelial fluid transport. J Membr Biol. 2006 Mar; 210(2):105-15. PMID: 16868675.
      View in: PubMed
    31. Levin M, Sullivan S, Nielson D, Yang B, Finkbeiner WE, Verkman AS. Hypertonic saline therapy in cystic fibrosis: Evidence against the proposed mechanism involving aquaporins. J Biol Chem. 2006 Sep 01; 281(35):25803-12. PMID: 16829520.
      View in: PubMed
    32. Levin M, Kim JK, Hu J, Verkman AS. Potential difference measurements of ocular surface Na+ absorption analyzed using an electrokinetic model. Invest Ophthalmol Vis Sci. 2006 Jan; 47(1):306-16. PMID: 16384978.
      View in: PubMed
    33. Levin M, Verkman AS. CFTR-regulated chloride transport at the ocular surface in living mice measured by potential differences. Invest Ophthalmol Vis Sci. 2005 Apr; 46(4):1428-34. PMID: 15790911.
      View in: PubMed
    34. Levin M, Verkman AS. Aquaporin-dependent water permeation at the mouse ocular surface: in vivo microfluorimetric measurements in cornea and conjunctiva. Invest Ophthalmol Vis Sci. 2004 Dec; 45(12):4423-32. PMID: 15557451.
      View in: PubMed
    35. Levin M, Haggie PM, Vetrivel L, Verkman AS. Diffusion in the endoplasmic reticulum of an aquaporin-2 mutant causing human nephrogenic diabetes insipidus. J Biol Chem. 2001 Jun 15; 276(24):21331-6. PMID: 11297561.
      View in: PubMed
    Marc's Networks
    Concepts
    Derived automatically from this person's publications.
    _
    Co-Authors
    People in Profiles who have published with this person.
    _
    Related Authors
    People who share related concepts with this person.
    _
    Back to TOP